Health, Vaccines, Lyme Disease, FDA, Medicine.
burgdorferi. Safety trials have also recruited people older than age two years, suggesting this vaccine could potentially be used in children. Although it targets the same outer surface proteins as the original Lyme disease vaccine, Valneva’s candidate does not make use of the epitope that was